Serveur d'exploration SRAS - Curation (Ncbi)

Index « Mesh.i » - entrée « Cathepsin L »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cathepsin B < Cathepsin L < Cathepsins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
001094 (2005) Graham Simmons [États-Unis] ; Dhaval N. Gosalia ; Andrew J. Rennekamp ; Jacqueline D. Reeves ; Scott L. Diamond ; Paul BatesInhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.
001223 (2005) Haroon AshrafCathepsin enzyme provides clue to SARS infection.
001301 (2006) I-Chueh Huang [États-Unis] ; Berend Jan Bosch ; Fang Li ; Wenhui Li ; Kyoung Hoa Lee ; Sorina Ghiran ; Natalya Vasilieva ; Terence S. Dermody ; Stephen C. Harrison ; Philip R. Dormitzer ; Michael Farzan ; Peter J M. Rottier ; Hyeryun ChoeSARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.
001669 (2007) S-Q Wang [République populaire de Chine] ; Q-S Du ; K. Zhao ; A-X Li ; D-Q Wei ; K-C ChouVirtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.
001702 (2006) Graham Simmons [États-Unis] ; Andrew J. Rennekamp ; Paul BatesProteolysis of SARS-associated coronavirus spike glycoprotein.
001710 (2006) I-Chueh Huang [États-Unis] ; Berend Jan Bosch ; Wenhui Li ; Michael Farzan ; Peter M. Rottier ; Hyeryun ChoeSARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry.
001B93 (2008) Konrad Stadler [Italie] ; Huy Riem Ha ; Vincenzo Ciminale ; Carlo Spirli ; Giulietta Saletti ; Marco Schiavon ; Daniela Bruttomesso ; Laurent Bigler ; Ferenc Follath ; Andrea Pettenazzo ; Aldo BaritussioAmiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level.
001C81 (2008) Berend Jan Bosch [Pays-Bas] ; Willem Bartelink ; Peter J M. RottierCathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide.
001D80 (2008) Miyuki Kawase [Japon] ; Kazuya Shirato [Japon] ; Shutoku Matsuyama [Japon] ; Fumihiro Taguchi [Japon]Protease-Mediated Entry via the Endosome of Human Coronavirus 229E▿
002135 (2010) Parag P. Shah [États-Unis] ; Tianhua Wang ; Rachel L. Kaletsky ; Michael C. Myers ; Jeremy E. Purvis ; Huiyan Jing ; Donna M. Huryn ; Doron C. Greenbaum ; Amos B. Smith ; Paul Bates ; Scott L. DiamondA small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.
002411 (2011) Sheila M. Pimentel-Elardo ; Verena Buback ; Tobias A. M. Gulder ; Tim S. Bugni ; Jason Reppart ; Gerhard Bringmann ; Chris M. Ireland ; Tanja Schirmeister ; Ute HentschelNew Tetromycin Derivatives with Anti-Trypanosomal and Protease Inhibitory Activities †
002674 (2013) Adeyemi O. Adedeji [États-Unis] ; William Severson ; Colleen Jonsson ; Kamalendra Singh ; Susan R. Weiss ; Stefan G. SarafianosNovel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms.
002823 (2014) Hatem A. Elshabrawy [États-Unis] ; Jilao Fan ; Christine S. Haddad ; Kiira Ratia ; Christopher C. Broder ; Michael Caffrey ; Bellur S. PrabhakarIdentification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
002C19 (2016) Nan Zhou ; Ting Pan ; Junsong Zhang ; Qianwen Li ; Xue Zhang ; Chuan Bai ; Feng Huang ; Tao Peng ; Jianhua Zhang ; Chao Liu ; Liang Tao ; Hui ZhangGlycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)*
002D18 (2016) Xiang Xu [États-Unis] ; John R. Greenland [États-Unis] ; Jeffrey E. Gotts [États-Unis] ; Michael A. Matthay [États-Unis] ; George H. Caughey [États-Unis]Cathepsin L Helps to Defend Mice from Infection with Influenza A
002D20 (2017) Kazuya Shirato [Japon] ; Kazuhiko Kanou [Japon] ; Miyuki Kawase [Japon] ; Shutoku Matsuyama [Japon]Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
002E43 (2017) Ali A. Rabaan [Arabie saoudite] ; Shamsah H. Alahmed [Arabie saoudite] ; Ali M. Bazzi [Arabie saoudite] ; Hatem M. Alhani [Arabie saoudite]A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective.
003094 (2019) Danying Chen [République populaire de Chine] ; Zhifei Hou [République populaire de Chine] ; Dong Jiang [République populaire de Chine] ; Mei Zheng [République populaire de Chine] ; Guoli Li [République populaire de Chine] ; Yue Zhang [République populaire de Chine] ; Rui Li [République populaire de Chine] ; Hanxin Lin [Canada] ; Jinhong Chang [États-Unis] ; Hui Zeng [République populaire de Chine] ; Ju-Tao Guo [États-Unis] ; Xuesen Zhao [République populaire de Chine]GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.
003588 (2020) Xiuyuan Ou [République populaire de Chine] ; Yan Liu [République populaire de Chine] ; Xiaobo Lei [République populaire de Chine] ; Pei Li [République populaire de Chine] ; Dan Mi [République populaire de Chine] ; Lili Ren [République populaire de Chine] ; Li Guo [République populaire de Chine] ; Ruixuan Guo [République populaire de Chine] ; Ting Chen [République populaire de Chine] ; Jiaxin Hu [République populaire de Chine] ; Zichun Xiang [République populaire de Chine] ; Zhixia Mu [République populaire de Chine] ; Xing Chen [République populaire de Chine] ; Jieyong Chen [République populaire de Chine] ; Keping Hu [République populaire de Chine] ; Qi Jin [République populaire de Chine] ; Jianwei Wang [République populaire de Chine] ; Zhaohui Qian [République populaire de Chine]Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Cathepsin L" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Cathepsin L" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Cathepsin L
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021